What is the CVSS score of CVE-2023-25289?

CVE-2023-25289 has a CVSS 3.1 base score of 7.5 (High). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N. EPSS exploitation probability: 7.7%.

Is there a public PoC exploit available for CVE-2023-25289?

Yes, a public proof-of-concept exploit is available for CVE-2023-25289. Prioritise patching immediately. EPSS: 7.7%.

Digital Reciptie CVE-2023-25289

HIGH

Path Traversal (CWE-22)

2023-05-04 cve@mitre.org

Path Traversal Digital Reciptie

7.5

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

7.5 HIGH

AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Attack Vector

Network

Attack Complexity

Low

Privileges Required

None

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

None

Availability

None

Lifecycle Timeline

CVE Published

May 04, 2023 - 21:15 nvd

HIGH 7.5

DescriptionNVD

AnalysisAI

Directory Traversal vulnerability in virtualreception Digital Receptie version win7sp1_rtm.101119-1850 6.1.7601.1.0.65792 in embedded web server, allows attacker to gain sensitive information via a. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity. Public exploit code available and no vendor patch available.

Technical ContextAI

This vulnerability is classified as Path Traversal (CWE-22), which allows attackers to access files and directories outside the intended path. Directory Traversal vulnerability in virtualreception Digital Receptie version win7sp1_rtm.101119-1850 6.1.7601.1.0.65792 in embedded web server, allows attacker to gain sensitive information via a crafted GET request. Affected products include: Virtualreception Digital Reciptie.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Validate and canonicalize file paths. Use chroot or sandboxing. Reject input containing path separators or '../' sequences.